LES Foundation | LESI | Print Page | Contact Us | Sign In | Join
Abacavir, a Licensing Success Story
Tell a Friend About This EventTell a Friend
Abacavir, a Licensing Success Story

Minnesota Chapter Meeting

When: Tuesday, April 12
11:30 - 1:00 pm
Where: Hamline University, West Location
1600 Utica Avenue, South
7th Floor
St. Louis Park, Minnesota  55416
United States
Contact: Frank Farrell

Online registration is closed.
« Go to Upcoming Event List  

Abacavir, A Licensing Success Story

Dr. Robert Vince invented the HIV drug abacavir which was licensed to and commercialized by Glaxo Smith Kline. That license has generated more than 600 million dollars in licensing revenue for the University of Minnesota. Abacavir also commonly known under the trade name Ziagen is on the World Health Organization’s List of Essential Medicines, which is a list of the most important list of medicines needed for a basic health care system. The invention and licensing of this drug is a Minnesota success story. LES is very proud honored to have Dr. Vince come and tell the story of how this important drug was developed and licensed.

LES Member:    $45
Non-Member:   $60

About Dr. Robert Vince

Dr. Vance holds a doctoral degree in medicinal chemistry and has been a member of the chemistry faculty at the University of Minnesota since 1967. In 2002 he established the Center for Drug Design within the Academic Health Center of the University of Minnesota and is currently the Center’s Director.